tiprankstipranks
Trending News
More News >
Creo Medical (GB:CREO)
:CREO
UK Market
Advertisement

Creo Medical (CREO) Technical Analysis

Compare
54 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Creo Medical’s (CREO) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Creo Medical is a Sell.
Creo Medical’s (CREO) 20-Day exponential moving average is 13.35, while Creo Medical’s (CREO) share price is 13.62p, making it a Buy.
Creo Medical’s (CREO) 50-Day exponential moving average is 13.21, while Creo Medical’s (CREO) share price is 13.62p, making it a Buy.

Creo Medical (CREO) Pivot Points

Aug 01, 2025, 01:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.50
12.87
13.25
13.62
14.00
14.37
14.75
Fibonacci
12.87
13.16
13.34
13.62
13.91
14.09
14.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Creo Medical (CREO) Moving Averages

Aug 01, 2025, 01:52 PM
Period
Simple
Exponential
MA5
13.80Sell
13.62Sell
MA10
13.45Sell
13.50Sell
MA20
13.03Buy
13.35Buy
MA50
13.68Sell
13.21Buy
MA100
12.53Buy
13.75Sell
MA200
15.12Sell
16.63Sell
Creo Medical’s (CREO) 10-Day exponential moving average is 13.50, while Creo Medical’s (CREO) share price is 13.62p, making it a Sell.
Creo Medical’s (CREO) 100-Day exponential moving average is 13.75, while Creo Medical’s (CREO) share price is 13.62p, making it a Sell.
Creo Medical’s (CREO) stock price is 13.62p and Creo Medical’s (CREO) 50-day simple moving average is 13.68, creating a Sell signal.
Creo Medical’s (CREO) stock price is 13.62p and Creo Medical’s (CREO) 100-day simple moving average is 12.53, creating a Buy signal.
Creo Medical’s (CREO) stock price is 13.62p and Creo Medical’s (CREO) 200-day simple moving average is 15.12, creating a Sell signal.

Creo Medical (CREO) Technical Indicators

Aug 01, 2025, 01:52 PM
Name
Value
Implied Action
RSI (14)
51.06
Neutral
STOCH (9,6)
51.52
Neutral
STOCHRSI (14)
55.95
Neutral
MACD (12,26)
0.14
Sell
ADX (14)
19.40
Buy
Williams %R
-58.91
Buy
CCI (14)
39.39
Neutral
ATR (14)
0.86
-
Ultimate Oscillator
46.75
Neutral
ROC
8.08
Buy
Creo Medical’s (CREO) Relative Strength Index (RSI) is 51.06, creating a Neutral signal.
Creo Medical’s (CREO) Trend Strength Indicator (ADX) is 19.40, creating a Buy signal.
Creo Medical’s (CREO) Commodity Channel Index (CCI) is 39.39, creating a Neutral signal.
Creo Medical’s (CREO) Price Rate of Change (ROC) is 8.08, creating a Buy signal.

FAQ

Is CREO a Buy, Hold, or Sell?
Based on CREO’s technical indicators, CREO is a Sell.
    What is CREO’s RSI (14)?
    CREO’s RSI (14) is 51.06, which suggests CREO is a Neutral.
      What is CREO’s MACD?
      CREO’s MACD is 0.14, which suggests CREO is a Sell.
        What is CREO’s 5-day moving average?
        CREO’s 5-day moving average is 13.80, which suggests CREO is a Sell.
          What is CREO’s 20-day moving average?
          CREO 20-day moving average is 13.03, which suggests CREO is a Buy.
            What is CREO’s 50-day moving average?
            CREO’s 50-day moving average is 13.68, which suggests CREO is a Sell.
              What is CREO’s 200-day moving average?
              CREO’s 200-day moving average is 15.12, which suggests CREO is a Sell.
                What is CREO’s Williams % R (14)?
                CREO’s Williams % R (14) is -58.91, which suggests CREO is a Buy.
                  What is CREO’s CCI (14)?
                  CREO’s CCI (14) is 39.39, which suggests CREO is a Neutral.
                    What is the share price of Creo Medical?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis